- Home
- SERA vs NCZ Comparison
SERA vs NCZ Comparison
Compare SERA & NCZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SERA
- NCZ
- Stock Information
- Founded
- SERA 2008
- NCZ 2003
- Country
- SERA United States
- NCZ United States
- Employees
- SERA N/A
- NCZ N/A
- Industry
- SERA Precision Instruments
- NCZ Finance Companies
- Sector
- SERA Health Care
- NCZ Finance
- Exchange
- SERA Nasdaq
- NCZ Nasdaq
- Market Cap
- SERA 70.4M
- NCZ 228.3M
- IPO Year
- SERA 2021
- NCZ N/A
- Fundamental
- Price
- SERA $2.58
- NCZ $12.82
- Analyst Decision
- SERA
- NCZ
- Analyst Count
- SERA 0
- NCZ 0
- Target Price
- SERA N/A
- NCZ N/A
- AVG Volume (30 Days)
- SERA 808.0K
- NCZ 533.0K
- Earning Date
- SERA 08-06-2025
- NCZ 01-01-0001
- Dividend Yield
- SERA N/A
- NCZ 12.16%
- EPS Growth
- SERA N/A
- NCZ N/A
- EPS
- SERA N/A
- NCZ N/A
- Revenue
- SERA $115,000.00
- NCZ N/A
- Revenue This Year
- SERA $390.13
- NCZ N/A
- Revenue Next Year
- SERA $440.54
- NCZ N/A
- P/E Ratio
- SERA N/A
- NCZ N/A
- Revenue Growth
- SERA N/A
- NCZ N/A
- 52 Week Low
- SERA $1.37
- NCZ $2.50
- 52 Week High
- SERA $9.13
- NCZ $3.15
- Technical
- Relative Strength Index (RSI)
- SERA 55.80
- NCZ 71.91
- Support Level
- SERA $1.82
- NCZ $12.49
- Resistance Level
- SERA $4.09
- NCZ $12.48
- Average True Range (ATR)
- SERA 0.37
- NCZ 0.14
- MACD
- SERA 0.17
- NCZ 0.04
- Stochastic Oscillator
- SERA 44.92
- NCZ 94.41
About SERA Sera Prognostics Inc.
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.
About NCZ Virtus Convertible & Income Fund II of Beneficial Interest
Virtus Convertible & Income Fund II is a diversified, closed-end management investment company. The investment objective of the company is to provide total return through a combination of capital appreciation and high current income. Its portfolio of investments includes different sector investments such as in healthcare services, media, oil, gas, and consumable fuels and others.